Related Experiment Video

Updated: Aug 14, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Markers of cardiac ischemia and inflammation

Tracy Y Wang1, Wael A AlJaroudi, L Kristin Newby

  • 1Division of Cardiology, Duke University Medical Center, Durham, NC 27710, USA.

Cardiology Clinics
|November 10, 2005
PubMed

Insights

Diagnosing myocardial infarction retrospectively is common. Novel biomarkers now detect early ischemia and coronary inflammation before heart muscle damage occurs, aiding in risk assessment for atherosclerosis patients.

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Atherosclerosis Research

Background:

  • Current diagnosis of myocardial infarction relies on biomarkers released after heart muscle cell death, necessitating retrospective analysis.
  • Identifying patients at risk for complications prior to myocardial necrosis is a significant clinical challenge.
  • Advancements in understanding atherothrombosis pathophysiology are crucial for developing new diagnostic tools.

Purpose of the Study:

  • To explore novel biomarkers for early detection of cardiovascular events.
  • To identify markers indicating ischemia without myocyte necrosis.
  • To find indicators of preclinical coronary inflammation in atherosclerosis patients.

Main Methods:

  • Review of current diagnostic limitations for myocardial infarction.
  • Analysis of insights from atherothrombosis pathophysiology.
  • Development and evaluation of novel biomarker strategies.

Main Results:

  • Biomarkers for myocardial necrosis are only positive after cellular damage has occurred.
  • Novel markers can detect early ischemia preceding myocyte death.
  • New markers identify early coronary inflammation in preclinical atherosclerosis.

Conclusions:

  • Retrospective diagnosis of myocardial infarction is a limitation of current methods.
  • Novel biomarkers offer the potential for earlier detection of adverse cardiac events.
  • These advancements may enable proactive management of patients with atherosclerosis and inflammation.

More Related Videos

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy06:38

Simultaneous 3D Analysis of Cardiac Damage and Immune Response in Reperfused Acute Myocardial Infarction Using Light Sheet Fluorescence Microscopy

Published on: September 26, 2025

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...